Developing gene therapies for rare diseases with a proprietary delivery platform.
http://www.priceseries.com/trade/RGNX-REGENXBIO-Inc-stock-gains-33-percent-a-Trade-Record-by-priceSeries-2018061820180712.html
Subscribe by Email
Follow Updates Articles from This Blog via Email
No Comments